Therapeutic revascularisation of ischaemic tissue: The opportunities and challenges for therapy using vascular stem/progenitor cells

Stem Cell Research and Therapy

Volumn 3, Issue 4, 2012, Pages

  O'Neill, Christina L ^a   O'Doherty, Michelle T ^a   Wilson, Sarah Ej ^a   Rana, Amer A ^b   Hirst, Claire E ^c   Stitt, Alan W ^a   Medina, Reinhold J ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT STEM CELL; ANGIOGENESIS; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CELL PROLIFERATION; EMBRYONIC STEM CELL; ENDOTHELIAL PROGENITOR CELL; HUMAN; ISCHEMIA; LIMB ISCHEMIA; MALIGNANT TRANSFORMATION; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVASCULARIZATION; REVIEW; STEM CELL TRANSPLANTATION; BIOLOGICAL THERAPY; CYTOLOGY; STEM CELL; VASCULAR ENDOTHELIUM;

ADULT STEM CELLS; CELL- AND TISSUE-BASED THERAPY; ENDOTHELIUM, VASCULAR; HUMANS; ISCHEMIA; NEOVASCULARIZATION, PHYSIOLOGIC; PLURIPOTENT STEM CELLS; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 84865246962     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt122     Document Type: Review

References (59)

1. Critical limb ischemia: medical and surgical management. Slovut DP, Sullivan TM, Vasc Med 2008 13 281 291 18687766
2. The comparative medical costs of atherothrombotic disease in European countries. Levy E, Gabriel S, Dinet J, PharmacoEconomics 2003 21 651 659 10.2165/00019053-200321090-00003 12807366 (Pubitemid 36808216)
3. Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challenges. Tongers J, Losordo DW, Landmesser U, Eur Heart J 2011 32 1197 1206 10.1093/eurheartj/ehr018 21362705
4. Autologous stem cell therapy for peripheral arterial disease meta-analysis and systematic review of the literature. Fadini GP, Agostini C, Avogaro A, Atherosclerosis 2010 209 10 17 10.1016/j.atherosclerosis.2009.08.033 19740466
5. Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Aicher A, Brenner W, Zuhayra M, Badorff C, Massoudi S, Assmus B, Eckey T, Henze E, Zeiher AM, Dimmeler S, Circulation 2003 107 2134 2139 10.1161/01.CIR.0000062649.63838.C9 12695305 (Pubitemid 36532196)
6. Obese diabetic mouse environment differentially affects primitive and monocytic endothelial cell progenitors. Awad O, Jiao C, Ma N, Dunnwald M, Schatteman GC, Stem Cells 2005 23 575 583 10.1634/stemcells.2004-0185 15790778 (Pubitemid 40478496)
7. Local implantation of autologous bone marrow cells for therapeutic angiogenesis in patients with ischemic heart disease: clinical trial and preliminary results. Hamano K, Nishida M, Hirata K, Mikamo A, Li TS, Harada M, Miura T, Matsuzaki M, Esato K, Jpn Circ J 2001 65 845 847 10.1253/jcj.65.845 11548889 (Pubitemid 32845720)
8. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD, Circulation 2002 105 93 98 10.1161/hc0102.101442 11772882 (Pubitemid 34049148)
9. + cell transplantation in severe hind limb ischemia. Aranguren XL, Pelacho B, Penuelas I, Abizanda G, Uriz M, Ecay M, Collantaes M, Arana M, Beerens M, Coppiello G, Perez-Ilzarbe M, Andreu EJ, Luttun A, Prosper F, Cell Transplant 2011 20 259 269 10.3727/096368910X516592 20719064
10. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, Li T, Isner JM, Asahara T, Proc Natl Acad Sci USA 2000 97 3422 3427 10725398 (Pubitemid 30183318)
11. Augmentation of neovascularization [corrected] in hindlimb ischemia by combined transplantation of human embryonic stem cells-derived endothelial and mural cells. Yamahara K, Sone M, Itoh H, Yamashita JK, Yurugi-Kobayashi T, Homma K, Chao TH, Miyashita K, Park K, Oyamada N, Sawada N, Taura D, Fukunaga Y, Tamura N, Nakao K, PloS One 2008 3 1666 10.1371/journal.pone.0001666 18301744 (Pubitemid 351865661)
12. Endothelial cells derived from human iPSCS increase capillary density and improve perfusion in a mouse model of peripheral arterial disease. Rufaihah AJ, Huang NF, Jame S, Lee JC, Nguyen HN, Byers B, De A, Okogbaa J, Rollins M, Reijo-Pera R, Gambhir SS, Cooke JP, Arterioscler Thromb Vasc Biol 2011 31 72 e79 10.1161/ATVBAHA.111.230938 21836062
13. Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Quevedo HC, Hatzistergos KE, Oskouei BN, Feigenbaum GS, Rodriguez JE, Valdes D, Pattany PM, Zambrano JP, Hu Q, McNiece I, Heldman AW, Hare JM, Proc Natl Acad Sci USA 2009 106 14022 14027 10.1073/pnas.0903201106 19666564
14. Cytokine-induced differentiation of multipotent adult progenitor cells into functional smooth muscle cells. Ross JJ, Hong Z, Willenbring B, Zeng L, Isenberg B, Lee EH, Reyes M, Keirstead SA, Weir EK, Verfaillie CM, J Clin Invest 2006 116 3139 3149 10.1172/JCI28184 17099777 (Pubitemid 44878628)
15. Human embryonic stem cell lines derived from single blastomeres. Klimanskaya I, Chung Y, Becker S, Lu SJ, Lanza R, Nature 2006 444 481 485 10.1038/nature05142 16929302 (Pubitemid 44809064)
16. The tumorigenicity of human embryonic stem cells. Blum B, Benvenisty N, Adv Cancer Res 2008 100 133 158 18620095 (Pubitemid 351932182)
17. Hematopoietic differentiation of human embryonic stem cells progresses through sequential hematoendothelial, primitive, and definitive stages resembling human yolk sac development. Zambidis ET, Peault B, Park TS, Bunz F, Civin CI, Blood 2005 106 860 870 10.1182/blood-2004-11-4522 15831705 (Pubitemid 41076425)
18. Hematopoietic colony-forming cells derived from human embryonic stem cells. Kaufman DS, Hanson ET, Lewis RL, Auerbach R, Thomson JA, Proc Natl Acad Sci USA 2001 98 10716 10721 10.1073/pnas.191362598 11535826 (Pubitemid 32878687)
19. Endothelial cells derived from human embryonic stem cells form durable blood vessels in vivo. Wang ZZ, Au P, Chen T, Shao Y, Daheron LM, Bai H, Arzigian M, Fukumura D, Jain RK, Scadden DT, Nat Biotechnol 2007 25 317 318 10.1038/nbt1287 17322871 (Pubitemid 46398769)
20. Endothelial potential of human embryonic stem cells. Levenberg S, Zoldan J, Basevitch Y, Langer R, Blood 2007 110 806 814 10.1182/blood-2006-08-019190 17412888 (Pubitemid 47267415)
21. Pathway for differentiation of human embryonic stem cells to vascular cell components and their potential for vascular regeneration. Sone M, Itoh H, Yamahara K, Yamashita JK, Yurugi-Kobayashi T, Nonoguchi A, Suzuki Y, Chao TH, Sawada N, Fukunaga Y, Miyashita K, Park K, Oyamada N, Sawada N, Taura D, Tamura N, Kondo Y, Nito S, Suemori H, Nakatsuji N, Nishikawa S, Nakao K, Arterioscler Thromb Vasc Biol 2007 27 2127 2134 10.1161/ATVBAHA.107.143149 17872458 (Pubitemid 350287240)
22. Improvement of postnatal neovascularization by human embryonic stem cell derived endothelial-like cell transplantation in a mouse model of hindlimb ischemia. Cho SW, Moon SH, Lee SH, Kang SW, Kim J, Lim JM, Kim HS, Kim BS, Chung HM, Circulation 2007 116 2409 2419 10.1161/CIRCULATIONAHA.106.687038 17984381 (Pubitemid 350147820)
23. + endothelial progenitor cells for cardiac repair. Rufaihah AJ, Haider HK, Heng BC, Ye L, Tan RS, Toh WS, Tian XF, Sim EK, Cao T, Regen Med 2010 5 231 244 10.2217/rme.09.83 20210583
24. Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. Weintraub H, Tapscott SJ, Davis RL, Thayer MJ, Adam MA, Lassar AB, Miller AD, Proc Natl Acad Sci USA 1989 86 5434 5438 10.1073/pnas.86.14.5434 2748593 (Pubitemid 19185563)
25. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Takahashi K, Yamanaka S, Cell 2006 126 663 676 10.1016/j.cell.2006.07.024 16904174 (Pubitemid 44233629)
26. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S, Cell 2007 131 861 872 10.1016/j.cell.2007.11.019 18035408 (Pubitemid 350138099)
27. Induction and isolation of vascular cells from human induced pluripotent stem cells-brief report. Taura D, Sone M, Homma K, Oyamada N, Takahashi K, Tamura N, Yamanaka S, Nakao K, Arterioscler Thromb Vasc Biol 2009 29 1100 1103 10.1161/ATVBAHA.108.182162 19423866
28. Mouse and human induced pluripotent stem cells as a source for multipotent Isl1+ cardiovascular progenitors. Moretti A, Bellin M, Jung CB, Thies TM, Takashima Y, Bernshausen A, Schiemann M, Fischer S, Moosmang S, Smith AG, Lam JT, Laugwitz KL, Faseb J 2010 24 700 711 10.1096/fj.09-139477 19850773
29. Efficient commitment to functional CD34+ progenitor cells from human bone marrow mesenchymal stem-cell-derived induced pluripotent stem cells. Xu Y, Liu L, Zhang L, Fu S, Hu Y, Wang Y, Fu H, Wu K, Xiao H, Liu S, Yu X, Zheng W, Feng B, Huang H, PloS One 2012 7 34321 10.1371/journal.pone.0034321 22496789
30. Induced pluripotent stem cells: opportunities and challenges. Okita K, Yamanaka S, Philos Trans R Soc Lond B Biol Sci 2011 366 2198 2207 10.1098/rstb.2011.0016 21727125
31. Dissecting the oncogenic and tumorigenic potential of differentiated human induced pluripotent stem cells and human embryonic stem cells. Ghosh Z, Huang M, Hu S, Wilson KD, Dey D, Wu JC, Cancer Res 2011 71 5030 5039 10.1158/0008-5472.CAN-10-4402 21646469
32. Copy number variation and selection during reprogramming to pluripotency. Hussein SM, Batada NN, Vuoristo S, Ching RW, Autio R, Narva E, Ng S, Sourour M, Hamalainen R, Olsson C, Lundin K, Mikkola M, Trokovic R, Peitz M, Brustle O, Bazette-Jones DP, Alitalo K, Lahesmaa R, Nagy A, Otonkoski T, Nature 2011 471 58 62 10.1038/nature09871 21368824
33. Somatic coding mutations in human induced pluripotent stem cells. Gore A, Li Z, Fung HL, Young JE, Agarwal S, Antosiewicz-Bourget J, Canto I, Giorgetti A, Israel MA, Kiskinis E, Lee JH, Loh YH, Manos PD, Montserrat N, Panopoulos AD, Ruiz S, Wilbert ML, Yu J, Kirkness EF, Izpisula Belmonte JC, Rossi DJ, Thomson JA, Eggan K, Daley GQ, Goldstein LS, Zhang K, Nature 2011 471 63 67 10.1038/nature09805 21368825
34. Epigenetic memory in induced pluripotent stem cells. Kim K, Doi A, Wen B, Ng K, Zhao R, Cahan P, Kim J, Aryee MJ, Ji H, Ehrlich LI, Yabuuchi A, Takeuchi A, Cunniff KC, Hongguang H, Mckinney-Freeman S, Naveiras O, Yoon TJ, Irizarry RA, Jung N, Seita J, Hanna J, Murakami P, Jaenisch R, Weissleder R, Orkin SH, Weissman IL, Feinberg AP, Daley GQ, Nature 2010 467 285 290 10.1038/nature09342 20644535
35. Circulating endothelial progenitor cells and cardiovascular outcomes. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Bohm M, Nickenig G, N Engl J Med 2005 353 999 1007 10.1056/NEJMoa043814 16148285 (Pubitemid 41262334)
36. Endothelial progenitors as tools to study vascular disease. Medina RJ, O'Neill CL, O'Doherty TM, Wilson SE, Stitt AW, Stem Cell Internat 2012 2012 346735 22550504
37. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F, Krasich R, Temm CJ, Prchal JT, Ingram DA, Blood 2007 109 1801 1809 10.1182/blood-2006-08-043471 17053059 (Pubitemid 46348173)
38. Isolation of putative progenitor endothelial cells for angiogenesis. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM, Science 1997 275 964 967 10.1126/science.275.5302.964 9020076 (Pubitemid 27087709)
39. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T, N Engl J Med 2003 348 593 600 10.1056/NEJMoa022287 12584367 (Pubitemid 36204953)
40. Immune cells mimic the morphology of endothelial progenitor colonies in vitro. Rohde E, Bartmann C, Schallmoser K, Reinisch A, Lanzer G, Linkesch W, Guelly C, Strunk D, Stem Cells 2007 25 1746 1752 10.1634/stemcells.2006-0833 17395771 (Pubitemid 47121853)
41. Bone marrow-derived cells do not incorporate into the adult growing vasculature. Ziegelhoeffer T, Fernandez B, Kostin S, Heil M, Voswinckel R, Helisch A, Schaper W, Circ Res 2004 94 230 238 10.1161/01.RES.0000110419.50982. 1C 14656934 (Pubitemid 38197456)
42. Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells. Ingram DA, Caplice NM, Yoder MC, Blood 2005 106 1525 1531 10.1182/blood-2005-04-1509 15905185 (Pubitemid 41208561)
43. Molecular analysis of endothelial progenitor cell (EPC) subtypes reveals two distinct cell populations with different identities. Medina RJ, O'Neill CL, Sweeney M, Guduric-Fuchs J, Gardiner TA, Simpson DA, Stitt AW, BMC Med Genomics 2010 3 18 10.1186/1755-8794-3-18 20465783
44. Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures. Prokopi M, Pula G, Mayr U, Devue C, Gallagher J, Xiao Q, Boulanger CM, Westwood N, Urbich C, Willeit J, Steiner M, Breuss J, Xu Q, Kiechi S, Mayr M, Blood 2009 114 723 732 10.1182/blood-2009-02- 205930 19369228
45. Myeloid angiogenic cells act as alternative M2 macrophages and modulate angiogenesis through interleukin-8. Medina RJ, O'Neill CL, O'Doherty TM, Knott H, Guduric-Fuchs J, Gardiner TA, Stitt AW, Mol Med 2011 17 1045 1055 21670847
46. Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay. Sieveking DP, Buckle A, Celermajer DS, Ng MK, J Am Coll Cardiol 2008 51 660 668 10.1016/j.jacc.2007.09.059 18261686 (Pubitemid 351186872)
47. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. Urbich C, Aicher A, Heeschen C, Dernbach E, Hofmann WK, Zeiher AM, Dimmeler S, J Mol Cell Cardiol 2005 39 733 742 10.1016/j.yjmcc.2005.07.003 16199052 (Pubitemid 41464410)
48. Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Urbich C, Heeschen C, Aicher A, Dernbach E, Zeiher AM, Dimmeler S, Circulation 2003 108 2511 2516 10.1161/01.CIR.0000096483.29777.50 14581410 (Pubitemid 37444414)
49. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Assmus B, Schachinger V, Teupe C, Britten M, Lehmann R, Dobert N, Grunwald F, Aicher A, Urbich C, Martin H, Hoelzer D, Dimmeler S, Zeiher AM, Circulation 2002 106 3009 3017 10.1161/01.CIR.0000043246. 74879.CD 12473544 (Pubitemid 35440281)
50. Origins of circulating endothelial cells and endothelial outgrowth from blood. Lin Y, Weisdorf DJ, Solovey A, Hebbel RP, J Clin Invest 2000 105 71 77 10.1172/JCI8071 10619863 (Pubitemid 30036389)
51. Humanized large-scale expanded endothelial colony-forming cells function in vitro and in vivo. Reinisch A, Hofmann NA, Obenauf AC, Kashofer K, Rohde E, Schallmoser K, Flicker K, Lanzer G, Linkesch W, Speicher MR, Strunk D, Blood 2009 113 6716 6725 10.1182/blood-2008-09-181362 19321860
52. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Ingram DA, Mead LE, Tanaka H, Meade V, Fenoglio A, Mortell K, Pollok K, Ferkowicz MJ, Gilley D, Yoder MC, Blood 2004 104 2752 2760 10.1182/blood-2004-04-1396 15226175 (Pubitemid 39434958)
53. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Hur J, Yoon CH, Kim HS, Choi JH, Kang HJ, Hwang KK, Oh BH, Lee MM, Park YB, Arterioscler Thromb Vasc Biol 2004 24 288 293 14699017 (Pubitemid 38197580)
54. Outgrowth endothelial cells: characterization and their potential for reversing ischemic retinopathy. Medina RJ, O'Neill CL, Humphreys MW, Gardiner TA, Stitt AW, Invest Ophthalmol Vis Sci 2010 51 5906 5913 10.1167/iovs.09-4951 20554606
55. Differential effects of progenitor cell populations on left ventricular remodeling and myocardial neovascularization after myocardial infarction. Dubois C, Liu X, Claus P, Marsboom G, Pokreisz P, Vandenwijngaert S, Depelteau H, Streb W, Chaothawee L, Maes F, Gheysens O, Debyser Z, Gillijns H, Pellens M, Vandendriessche T, Chuah M, Collen D, Verbeken E, Belmans A, Van de Werf F, Bogaert J, Janssens S, J Am Coll Cardiol 2010 55 2232 2243 10.1016/j.jacc.2009. 10.081 20466204
56. Blood outgrowth endothelial cell migration and trapping in vivo: a window into gene therapy. Milbauer LC, Enenstein JA, Roney M, Solovey A, Bodempudi V, Nichols TC, Hebbel RP, Transl Res 2009 153 179 189 10.1016/j.trsl.2008.12.009 19304277
57. Cell-based therapies for diabetic retinopathy. Shaw LC, Neu MB, Grant MB, Curr Diab Rep 2011 11 265 274 10.1007/s11892-011-0197-8 21611766
58. The relative potency and safety of endothelial progenitor cells and unselected mononuclear cells for recovery from myocardial infarction and ischemia. Sekiguchi H, Ii M, Losordo DW, J Cell Physiol 2009 219 235 242 10.1002/jcp.21672 19115244
59. + cell therapy for refractory angina. Losordo DW, Henry TD, Davidson C, Sup Lee J, Costa MA, Bass T, Mendelsohn F, Fortuin FD, Pepine CJ, Traverse JH, Amrani D, Ewenstein BM, Riedel N, Story K, Barker K, Povsic TJ, Harrington RA, Schatz RA, ACT34-CMI Investigators, Circ Res 2011 109 428 436 10.1161/CIRCRESAHA.111.245993 21737787